Posted: February 12, 2020 Dr. Lisa Fucito As of early December 2019, the Centers for Disease Control and Prevention (CDC) have received reports from all 50 states, Puerto Rico, the […] Read more
PROVIDER RESOURCES
MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC
INDUSTRY SUPPORTED
COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events